<DOC>
	<DOCNO>NCT02364115</DOCNO>
	<brief_summary>The purpose study investigate effectiveness stereotactic body radiotherapy patient bone metastatic disease .</brief_summary>
	<brief_title>Randomized Trial Comparing Conventional Radiotherapy With Stereotactic Radiotherapy Patients With Bone Metastases - VERTICAL Study</brief_title>
	<detailed_description>Rationale : Bone metastases frequent distant manifestation solid tumour , many bone metastasis locate spine . These patient mostly present severe ( back ) pain reduces quality life . The primary treatment pain management single-fraction low dose external beam radiation therapy ( EBRT ) , effective achieve pain reduction around 60 % patient , 0-23 % experience complete pain response . Recently , grow evidence Stereotactic Body Radiotherapy ( SBRT ) achieve much high pain response due high dose administer . In retrospective prospective case series , SBRT spinal , also non-spinal metastasis demonstrate safe , efficacious . However , randomize control trial perform . Objective : To study whether pain response three month patient osseous metastatic disease increase SBRT comparison low dose EBRT . Study design : Randomized controlled trial , VERTICAL study , nest within PRESENT cohort . Study population : Eligible patient MRI-compatible patient radiographic evidence bone metastasis radiotherapy department . Fifty-five patient recruit control intervention arm . Intervention : Patients undergo MRI-based , cone beam CT-guided SBRT receive single dose 18 Gray ( Gy ) visible metastasis , 8 Gy bony compartment contain metastasis ( e.g . affected vertebra pedicle ) . Main study parameters/endpoints : The primary endpoint pain control three month radiotherapy . Secondary outcome , among others , occurrence vertebral compression fracture ( VCF ) radiation-induced myelopathy , local tumour control evaluation quality life .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<criteria>Radiographic evidence bone metastasis For spinal lesion ; per lesion 3 consecutive spine segment involve one unaffected vertebral body No 2 painful lesion need treatment Histologic proof malignancy No compression spinal cord No mild neurological sign ( i.e . radiculopathy , dermatomal sensory change , muscle strength involve extremity Medical Research Council ( MRC ) 4/5 Medically inoperable patient refuse surgery Karnofsky performance score ( KPS ) &gt; 50 Numeric rating scale ( NRS ) &gt; 3 Age &gt; 18 year Written inform consent Filling PRESENTquestionnaires Lesion C1 C2 Radiosensitive histology multiple myeloma , lymphoma , small cell , germ cell Spinal MRI complete reason ( accord MRI protocol Department Radiology ) Impossible delineate metastasis organ risk ( OAR ) due artifact CT MRI previous surgical stabilization Unable undergo SBRT treatment , accord treat doctor 's opinion Epidural disease Severe , worsen progressive neurological deficit Unstable lesion require surgical stabilization Patient &lt; 3 month life expectancy Previous EBRT SBRT level Chemotherapy systemic radionuclide delivery within 24 hour SBRT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Spinal metastasis</keyword>
	<keyword>Spinal metastatic disease</keyword>
	<keyword>Stereotactic Body Radiotherapy</keyword>
	<keyword>Response</keyword>
	<keyword>Bone metastasis</keyword>
</DOC>